Ransomware group everest hits ABL Bio
ABL Bio — a healthcare target has been listed by the everest ransomware group on 2026-11-20. The information below reflects what the threat actor has publicly claimed on their leak site; the details have not been independently verified.
Incident Report
| Target Organization | ABL Bio |
|---|---|
| Threat Group | everest |
| Summary | ABL Bio, a healthcare organization, was listed by the everest ransomware group on its leak site on 2026-11-20. |
| Date of Breach | 2026-11-20 |
| Discovery Date | 2026-11-20 |
| Region | — |
| Target Domain | ablbio.com |
| Business Sector | Healthcare |
| Severity | MEDIUM |
Claim by everest
[AI generated] ABL Bio is a South Korean biopharmaceutical company based in Seongnam, South Korea. It specializes in the research and development of novel antibody therapeutics, focusing on areas such as oncology, immuno-oncology, and neurodegenerative diseases. The company is known for its bispecific antibody platform technology, including the Grabody platform used for brain-targeted drug delivery. ABL Bio operates in the biotechnology and pharmaceutical industry, partnering with global drug companies.
Posted by the everest threat actor on its public leak site. This is the group's own statement and has not been independently verified by HackerFeeds.
Sources
Victim website
ablbio.com
Leak post (onion / Tor)
http://everestndkvzcibcje2cqxhre2hmmybl3rn2gwzwsblz7gx6uryn5rad.onion/news/abl-bio
Open this URL in Tor Browser. Browsing leak sites carries real risk — view passively, never click further.
Disclaimer
HackerFeeds does not engage in the exfiltration, downloading, taking, hosting, viewing, reposting, or disclosure of any stolen information. All breach data reported here is sourced from publicly available threat intelligence feeds for awareness purposes only.

